1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Direct-to-consumer Disease Risk and Health Test Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Celiac Disease
        1.2.3 Parkinson Disease
        1.2.4 Alzheimer Disease
        1.2.5 Other
    1.3 Market by Application
        1.3.1 Global Direct-to-consumer Disease Risk and Health Test Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Online
        1.3.3 Offline
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Direct-to-consumer Disease Risk and Health Test Market Perspective (2017-2028)
    2.2 Direct-to-consumer Disease Risk and Health Test Growth Trends by Region
        2.2.1 Direct-to-consumer Disease Risk and Health Test Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Direct-to-consumer Disease Risk and Health Test Historic Market Size by Region (2017-2022)
        2.2.3 Direct-to-consumer Disease Risk and Health Test Forecasted Market Size by Region (2023-2028)
    2.3 Direct-to-consumer Disease Risk and Health Test Market Dynamics
        2.3.1 Direct-to-consumer Disease Risk and Health Test Industry Trends
        2.3.2 Direct-to-consumer Disease Risk and Health Test Market Drivers
        2.3.3 Direct-to-consumer Disease Risk and Health Test Market Challenges
        2.3.4 Direct-to-consumer Disease Risk and Health Test Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Direct-to-consumer Disease Risk and Health Test Players by Revenue
        3.1.1 Global Top Direct-to-consumer Disease Risk and Health Test Players by Revenue (2017-2022)
        3.1.2 Global Direct-to-consumer Disease Risk and Health Test Revenue Market Share by Players (2017-2022)
    3.2 Global Direct-to-consumer Disease Risk and Health Test Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Direct-to-consumer Disease Risk and Health Test Revenue
    3.4 Global Direct-to-consumer Disease Risk and Health Test Market Concentration Ratio
        3.4.1 Global Direct-to-consumer Disease Risk and Health Test Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Direct-to-consumer Disease Risk and Health Test Revenue in 2021
    3.5 Direct-to-consumer Disease Risk and Health Test Key Players Head office and Area Served
    3.6 Key Players Direct-to-consumer Disease Risk and Health Test Product Solution and Service
    3.7 Date of Enter into Direct-to-consumer Disease Risk and Health Test Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Direct-to-consumer Disease Risk and Health Test Breakdown Data by Type
    4.1 Global Direct-to-consumer Disease Risk and Health Test Historic Market Size by Type (2017-2022)
    4.2 Global Direct-to-consumer Disease Risk and Health Test Forecasted Market Size by Type (2023-2028)
5 Direct-to-consumer Disease Risk and Health Test Breakdown Data by Application
    5.1 Global Direct-to-consumer Disease Risk and Health Test Historic Market Size by Application (2017-2022)
    5.2 Global Direct-to-consumer Disease Risk and Health Test Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Direct-to-consumer Disease Risk and Health Test Market Size (2017-2028)
    6.2 North America Direct-to-consumer Disease Risk and Health Test Market Size by Type
        6.2.1 North America Direct-to-consumer Disease Risk and Health Test Market Size by Type (2017-2022)
        6.2.2 North America Direct-to-consumer Disease Risk and Health Test Market Size by Type (2023-2028)
        6.2.3 North America Direct-to-consumer Disease Risk and Health Test Market Share by Type (2017-2028)
    6.3 North America Direct-to-consumer Disease Risk and Health Test Market Size by Application
        6.3.1 North America Direct-to-consumer Disease Risk and Health Test Market Size by Application (2017-2022)
        6.3.2 North America Direct-to-consumer Disease Risk and Health Test Market Size by Application (2023-2028)
        6.3.3 North America Direct-to-consumer Disease Risk and Health Test Market Share by Application (2017-2028)
    6.4 North America Direct-to-consumer Disease Risk and Health Test Market Size by Country
        6.4.1 North America Direct-to-consumer Disease Risk and Health Test Market Size by Country (2017-2022)
        6.4.2 North America Direct-to-consumer Disease Risk and Health Test Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Direct-to-consumer Disease Risk and Health Test Market Size (2017-2028)
    7.2 Europe Direct-to-consumer Disease Risk and Health Test Market Size by Type
        7.2.1 Europe Direct-to-consumer Disease Risk and Health Test Market Size by Type (2017-2022)
        7.2.2 Europe Direct-to-consumer Disease Risk and Health Test Market Size by Type (2023-2028)
        7.2.3 Europe Direct-to-consumer Disease Risk and Health Test Market Share by Type (2017-2028)
    7.3 Europe Direct-to-consumer Disease Risk and Health Test Market Size by Application
        7.3.1 Europe Direct-to-consumer Disease Risk and Health Test Market Size by Application (2017-2022)
        7.3.2 Europe Direct-to-consumer Disease Risk and Health Test Market Size by Application (2023-2028)
        7.3.3 Europe Direct-to-consumer Disease Risk and Health Test Market Share by Application (2017-2028)
    7.4 Europe Direct-to-consumer Disease Risk and Health Test Market Size by Country
        7.4.1 Europe Direct-to-consumer Disease Risk and Health Test Market Size by Country (2017-2022)
        7.4.2 Europe Direct-to-consumer Disease Risk and Health Test Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Direct-to-consumer Disease Risk and Health Test Market Size (2017-2028)
    8.2 Asia-Pacific Direct-to-consumer Disease Risk and Health Test Market Size by Type
        8.2.1 Asia-Pacific Direct-to-consumer Disease Risk and Health Test Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Direct-to-consumer Disease Risk and Health Test Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Direct-to-consumer Disease Risk and Health Test Market Share by Type (2017-2028)
    8.3 Asia-Pacific Direct-to-consumer Disease Risk and Health Test Market Size by Application
        8.3.1 Asia-Pacific Direct-to-consumer Disease Risk and Health Test Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Direct-to-consumer Disease Risk and Health Test Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Direct-to-consumer Disease Risk and Health Test Market Share by Application (2017-2028)
    8.4 Asia-Pacific Direct-to-consumer Disease Risk and Health Test Market Size by Region
        8.4.1 Asia-Pacific Direct-to-consumer Disease Risk and Health Test Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Direct-to-consumer Disease Risk and Health Test Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Direct-to-consumer Disease Risk and Health Test Market Size (2017-2028)
    9.2 Latin America Direct-to-consumer Disease Risk and Health Test Market Size by Type
        9.2.1 Latin America Direct-to-consumer Disease Risk and Health Test Market Size by Type (2017-2022)
        9.2.2 Latin America Direct-to-consumer Disease Risk and Health Test Market Size by Type (2023-2028)
        9.2.3 Latin America Direct-to-consumer Disease Risk and Health Test Market Share by Type (2017-2028)
    9.3 Latin America Direct-to-consumer Disease Risk and Health Test Market Size by Application
        9.3.1 Latin America Direct-to-consumer Disease Risk and Health Test Market Size by Application (2017-2022)
        9.3.2 Latin America Direct-to-consumer Disease Risk and Health Test Market Size by Application (2023-2028)
        9.3.3 Latin America Direct-to-consumer Disease Risk and Health Test Market Share by Application (2017-2028)
    9.4 Latin America Direct-to-consumer Disease Risk and Health Test Market Size by Country
        9.4.1 Latin America Direct-to-consumer Disease Risk and Health Test Market Size by Country (2017-2022)
        9.4.2 Latin America Direct-to-consumer Disease Risk and Health Test Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Direct-to-consumer Disease Risk and Health Test Market Size (2017-2028)
    10.2 Middle East & Africa Direct-to-consumer Disease Risk and Health Test Market Size by Type
        10.2.1 Middle East & Africa Direct-to-consumer Disease Risk and Health Test Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Direct-to-consumer Disease Risk and Health Test Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Direct-to-consumer Disease Risk and Health Test Market Share by Type (2017-2028)
    10.3 Middle East & Africa Direct-to-consumer Disease Risk and Health Test Market Size by Application
        10.3.1 Middle East & Africa Direct-to-consumer Disease Risk and Health Test Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Direct-to-consumer Disease Risk and Health Test Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Direct-to-consumer Disease Risk and Health Test Market Share by Application (2017-2028)
    10.4 Middle East & Africa Direct-to-consumer Disease Risk and Health Test Market Size by Country
        10.4.1 Middle East & Africa Direct-to-consumer Disease Risk and Health Test Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Direct-to-consumer Disease Risk and Health Test Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 23andMe
        11.1.1 23andMe Company Details
        11.1.2 23andMe Business Overview
        11.1.3 23andMe Direct-to-consumer Disease Risk and Health Test Introduction
        11.1.4 23andMe Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
        11.1.5 23andMe Recent Developments
    11.2 MyHeritage
        11.2.1 MyHeritage Company Details
        11.2.2 MyHeritage Business Overview
        11.2.3 MyHeritage Direct-to-consumer Disease Risk and Health Test Introduction
        11.2.4 MyHeritage Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
        11.2.5 MyHeritage Recent Developments
    11.3 LabCorp
        11.3.1 LabCorp Company Details
        11.3.2 LabCorp Business Overview
        11.3.3 LabCorp Direct-to-consumer Disease Risk and Health Test Introduction
        11.3.4 LabCorp Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
        11.3.5 LabCorp Recent Developments
    11.4 Myriad Genetics
        11.4.1 Myriad Genetics Company Details
        11.4.2 Myriad Genetics Business Overview
        11.4.3 Myriad Genetics Direct-to-consumer Disease Risk and Health Test Introduction
        11.4.4 Myriad Genetics Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
        11.4.5 Myriad Genetics Recent Developments
    11.5 Ancestry.com
        11.5.1 Ancestry.com Company Details
        11.5.2 Ancestry.com Business Overview
        11.5.3 Ancestry.com Direct-to-consumer Disease Risk and Health Test Introduction
        11.5.4 Ancestry.com Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
        11.5.5 Ancestry.com Recent Developments
    11.6 Quest Diagnostics
        11.6.1 Quest Diagnostics Company Details
        11.6.2 Quest Diagnostics Business Overview
        11.6.3 Quest Diagnostics Direct-to-consumer Disease Risk and Health Test Introduction
        11.6.4 Quest Diagnostics Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
        11.6.5 Quest Diagnostics Recent Developments
    11.7 Gene By Gene
        11.7.1 Gene By Gene Company Details
        11.7.2 Gene By Gene Business Overview
        11.7.3 Gene By Gene Direct-to-consumer Disease Risk and Health Test Introduction
        11.7.4 Gene By Gene Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
        11.7.5 Gene By Gene Recent Developments
    11.8 DNA Diagnostics Center
        11.8.1 DNA Diagnostics Center Company Details
        11.8.2 DNA Diagnostics Center Business Overview
        11.8.3 DNA Diagnostics Center Direct-to-consumer Disease Risk and Health Test Introduction
        11.8.4 DNA Diagnostics Center Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
        11.8.5 DNA Diagnostics Center Recent Developments
    11.9 Invitae
        11.9.1 Invitae Company Details
        11.9.2 Invitae Business Overview
        11.9.3 Invitae Direct-to-consumer Disease Risk and Health Test Introduction
        11.9.4 Invitae Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
        11.9.5 Invitae Recent Developments
    11.10 IntelliGenetics
        11.10.1 IntelliGenetics Company Details
        11.10.2 IntelliGenetics Business Overview
        11.10.3 IntelliGenetics Direct-to-consumer Disease Risk and Health Test Introduction
        11.10.4 IntelliGenetics Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
        11.10.5 IntelliGenetics Recent Developments
    11.11 Ambry Genetics
        11.11.1 Ambry Genetics Company Details
        11.11.2 Ambry Genetics Business Overview
        11.11.3 Ambry Genetics Direct-to-consumer Disease Risk and Health Test Introduction
        11.11.4 Ambry Genetics Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
        11.11.5 Ambry Genetics Recent Developments
    11.12 Living DNA
        11.12.1 Living DNA Company Details
        11.12.2 Living DNA Business Overview
        11.12.3 Living DNA Direct-to-consumer Disease Risk and Health Test Introduction
        11.12.4 Living DNA Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
        11.12.5 Living DNA Recent Developments
    11.13 EasyDNA
        11.13.1 EasyDNA Company Details
        11.13.2 EasyDNA Business Overview
        11.13.3 EasyDNA Direct-to-consumer Disease Risk and Health Test Introduction
        11.13.4 EasyDNA Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
        11.13.5 EasyDNA Recent Developments
    11.14 Pathway Genomics
        11.14.1 Pathway Genomics Company Details
        11.14.2 Pathway Genomics Business Overview
        11.14.3 Pathway Genomics Direct-to-consumer Disease Risk and Health Test Introduction
        11.14.4 Pathway Genomics Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
        11.14.5 Pathway Genomics Recent Developments
    11.15 Centrillion Technology
        11.15.1 Centrillion Technology Company Details
        11.15.2 Centrillion Technology Business Overview
        11.15.3 Centrillion Technology Direct-to-consumer Disease Risk and Health Test Introduction
        11.15.4 Centrillion Technology Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
        11.15.5 Centrillion Technology Recent Developments
    11.16 Xcode
        11.16.1 Xcode Company Details
        11.16.2 Xcode Business Overview
        11.16.3 Xcode Direct-to-consumer Disease Risk and Health Test Introduction
        11.16.4 Xcode Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
        11.16.5 Xcode Recent Developments
    11.17 Color Genomics
        11.17.1 Color Genomics Company Details
        11.17.2 Color Genomics Business Overview
        11.17.3 Color Genomics Direct-to-consumer Disease Risk and Health Test Introduction
        11.17.4 Color Genomics Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
        11.17.5 Color Genomics Recent Developments
    11.18 Anglia DNA Services
        11.18.1 Anglia DNA Services Company Details
        11.18.2 Anglia DNA Services Business Overview
        11.18.3 Anglia DNA Services Direct-to-consumer Disease Risk and Health Test Introduction
        11.18.4 Anglia DNA Services Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
        11.18.5 Anglia DNA Services Recent Developments
    11.19 African Ancestry
        11.19.1 African Ancestry Company Details
        11.19.2 African Ancestry Business Overview
        11.19.3 African Ancestry Direct-to-consumer Disease Risk and Health Test Introduction
        11.19.4 African Ancestry Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
        11.19.5 African Ancestry Recent Developments
    11.20 Canadian DNA Services
        11.20.1 Canadian DNA Services Company Details
        11.20.2 Canadian DNA Services Business Overview
        11.20.3 Canadian DNA Services Direct-to-consumer Disease Risk and Health Test Introduction
        11.20.4 Canadian DNA Services Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
        11.20.5 Canadian DNA Services Recent Developments
    11.21 DNA Family Check
        11.21.1 DNA Family Check Company Details
        11.21.2 DNA Family Check Business Overview
        11.21.3 DNA Family Check Direct-to-consumer Disease Risk and Health Test Introduction
        11.21.4 DNA Family Check Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
        11.21.5 DNA Family Check Recent Developments
    11.22 Alpha Biolaboratories
        11.22.1 Alpha Biolaboratories Company Details
        11.22.2 Alpha Biolaboratories Business Overview
        11.22.3 Alpha Biolaboratories Direct-to-consumer Disease Risk and Health Test Introduction
        11.22.4 Alpha Biolaboratories Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
        11.22.5 Alpha Biolaboratories Recent Developments
    11.23 Test Me DNA
        11.23.1 Test Me DNA Company Details
        11.23.2 Test Me DNA Business Overview
        11.23.3 Test Me DNA Direct-to-consumer Disease Risk and Health Test Introduction
        11.23.4 Test Me DNA Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
        11.23.5 Test Me DNA Recent Developments
    11.24 23 Mofang
        11.24.1 23 Mofang Company Details
        11.24.2 23 Mofang Business Overview
        11.24.3 23 Mofang Direct-to-consumer Disease Risk and Health Test Introduction
        11.24.4 23 Mofang Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
        11.24.5 23 Mofang Recent Developments
    11.25 Genetic Health
        11.25.1 Genetic Health Company Details
        11.25.2 Genetic Health Business Overview
        11.25.3 Genetic Health Direct-to-consumer Disease Risk and Health Test Introduction
        11.25.4 Genetic Health Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
        11.25.5 Genetic Health Recent Developments
    11.26 DNA Services of America
        11.26.1 DNA Services of America Company Details
        11.26.2 DNA Services of America Business Overview
        11.26.3 DNA Services of America Direct-to-consumer Disease Risk and Health Test Introduction
        11.26.4 DNA Services of America Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
        11.26.5 DNA Services of America Recent Developments
    11.27 Shuwen Health Sciences
        11.27.1 Shuwen Health Sciences Company Details
        11.27.2 Shuwen Health Sciences Business Overview
        11.27.3 Shuwen Health Sciences Direct-to-consumer Disease Risk and Health Test Introduction
        11.27.4 Shuwen Health Sciences Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
        11.27.5 Shuwen Health Sciences Recent Developments
    11.28 Mapmygenome
        11.28.1 Mapmygenome Company Details
        11.28.2 Mapmygenome Business Overview
        11.28.3 Mapmygenome Direct-to-consumer Disease Risk and Health Test Introduction
        11.28.4 Mapmygenome Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
        11.28.5 Mapmygenome Recent Developments
    11.29 Full Genomes
        11.29.1 Full Genomes Company Details
        11.29.2 Full Genomes Business Overview
        11.29.3 Full Genomes Direct-to-consumer Disease Risk and Health Test Introduction
        11.29.4 Full Genomes Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
        11.29.5 Full Genomes Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Direct-to-consumer Disease Risk and Health Test Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Celiac Disease
    Table 3. Key Players of Parkinson Disease
    Table 4. Key Players of Alzheimer Disease
    Table 5. Key Players of Other
    Table 6. Global Direct-to-consumer Disease Risk and Health Test Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 7. Global Direct-to-consumer Disease Risk and Health Test Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Direct-to-consumer Disease Risk and Health Test Market Size by Region (2017-2022) & (US$ Million)
    Table 9. Global Direct-to-consumer Disease Risk and Health Test Market Share by Region (2017-2022)
    Table 10. Global Direct-to-consumer Disease Risk and Health Test Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 11. Global Direct-to-consumer Disease Risk and Health Test Market Share by Region (2023-2028)
    Table 12. Direct-to-consumer Disease Risk and Health Test Market Trends
    Table 13. Direct-to-consumer Disease Risk and Health Test Market Drivers
    Table 14. Direct-to-consumer Disease Risk and Health Test Market Challenges
    Table 15. Direct-to-consumer Disease Risk and Health Test Market Restraints
    Table 16. Global Direct-to-consumer Disease Risk and Health Test Revenue by Players (2017-2022) & (US$ Million)
    Table 17. Global Direct-to-consumer Disease Risk and Health Test Revenue Share by Players (2017-2022)
    Table 18. Global Top Direct-to-consumer Disease Risk and Health Test by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Direct-to-consumer Disease Risk and Health Test as of 2021)
    Table 19. Ranking of Global Top Direct-to-consumer Disease Risk and Health Test Companies by Revenue (US$ Million) in 2021
    Table 20. Global 5 Largest Players Market Share by Direct-to-consumer Disease Risk and Health Test Revenue (CR5 and HHI) & (2017-2022)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Direct-to-consumer Disease Risk and Health Test Product Solution and Service
    Table 23. Date of Enter into Direct-to-consumer Disease Risk and Health Test Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Direct-to-consumer Disease Risk and Health Test Market Size by Type (2017-2022) & (US$ Million)
    Table 26. Global Direct-to-consumer Disease Risk and Health Test Revenue Market Share by Type (2017-2022)
    Table 27. Global Direct-to-consumer Disease Risk and Health Test Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 28. Global Direct-to-consumer Disease Risk and Health Test Revenue Market Share by Type (2023-2028)
    Table 29. Global Direct-to-consumer Disease Risk and Health Test Market Size by Application (2017-2022) & (US$ Million)
    Table 30. Global Direct-to-consumer Disease Risk and Health Test Revenue Share by Application (2017-2022)
    Table 31. Global Direct-to-consumer Disease Risk and Health Test Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 32. Global Direct-to-consumer Disease Risk and Health Test Revenue Share by Application (2023-2028)
    Table 33. North America Direct-to-consumer Disease Risk and Health Test Market Size by Type (2017-2022) & (US$ Million)
    Table 34. North America Direct-to-consumer Disease Risk and Health Test Market Size by Type (2023-2028) & (US$ Million)
    Table 35. North America Direct-to-consumer Disease Risk and Health Test Market Size by Application (2017-2022) & (US$ Million)
    Table 36. North America Direct-to-consumer Disease Risk and Health Test Market Size by Application (2023-2028) & (US$ Million)
    Table 37. North America Direct-to-consumer Disease Risk and Health Test Market Size by Country (2017-2022) & (US$ Million)
    Table 38. North America Direct-to-consumer Disease Risk and Health Test Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Europe Direct-to-consumer Disease Risk and Health Test Market Size by Type (2017-2022) & (US$ Million)
    Table 40. Europe Direct-to-consumer Disease Risk and Health Test Market Size by Type (2023-2028) & (US$ Million)
    Table 41. Europe Direct-to-consumer Disease Risk and Health Test Market Size by Application (2017-2022) & (US$ Million)
    Table 42. Europe Direct-to-consumer Disease Risk and Health Test Market Size by Application (2023-2028) & (US$ Million)
    Table 43. Europe Direct-to-consumer Disease Risk and Health Test Market Size by Country (2017-2022) & (US$ Million)
    Table 44. Europe Direct-to-consumer Disease Risk and Health Test Market Size by Country (2023-2028) & (US$ Million)
    Table 45. Asia Pacific Direct-to-consumer Disease Risk and Health Test Market Size by Type (2017-2022) & (US$ Million)
    Table 46. Asia Pacific Direct-to-consumer Disease Risk and Health Test Market Size by Type (2023-2028) & (US$ Million)
    Table 47. Asia Pacific Direct-to-consumer Disease Risk and Health Test Market Size by Application (2017-2022) & (US$ Million)
    Table 48. Asia Pacific Direct-to-consumer Disease Risk and Health Test Market Size by Application (2023-2028) & (US$ Million)
    Table 49. Asia Pacific Direct-to-consumer Disease Risk and Health Test Market Size by Region (2017-2022) & (US$ Million)
    Table 50. Asia Pacific Direct-to-consumer Disease Risk and Health Test Market Size by Region (2023-2028) & (US$ Million)
    Table 51. Latin America Direct-to-consumer Disease Risk and Health Test Market Size by Type (2017-2022) & (US$ Million)
    Table 52. Latin America Direct-to-consumer Disease Risk and Health Test Market Size by Type (2023-2028) & (US$ Million)
    Table 53. Latin America Direct-to-consumer Disease Risk and Health Test Market Size by Application (2017-2022) & (US$ Million)
    Table 54. Latin America Direct-to-consumer Disease Risk and Health Test Market Size by Application (2023-2028) & (US$ Million)
    Table 55. Latin America Direct-to-consumer Disease Risk and Health Test Market Size by Country (2017-2022) & (US$ Million)
    Table 56. Latin America Direct-to-consumer Disease Risk and Health Test Market Size by Country (2023-2028) & (US$ Million)
    Table 57. Middle East and Africa Direct-to-consumer Disease Risk and Health Test Market Size by Type (2017-2022) & (US$ Million)
    Table 58. Middle East and Africa Direct-to-consumer Disease Risk and Health Test Market Size by Type (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa Direct-to-consumer Disease Risk and Health Test Market Size by Application (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa Direct-to-consumer Disease Risk and Health Test Market Size by Application (2023-2028) & (US$ Million)
    Table 61. Middle East and Africa Direct-to-consumer Disease Risk and Health Test Market Size by Country (2017-2022) & (US$ Million)
    Table 62. Middle East and Africa Direct-to-consumer Disease Risk and Health Test Market Size by Country (2023-2028) & (US$ Million)
    Table 63. 23andMe Company Details
    Table 64. 23andMe Business Overview
    Table 65. 23andMe Direct-to-consumer Disease Risk and Health Test Product
    Table 66. 23andMe Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) & (US$ Million)
    Table 67. 23andMe Recent Developments
    Table 68. MyHeritage Company Details
    Table 69. MyHeritage Business Overview
    Table 70. MyHeritage Direct-to-consumer Disease Risk and Health Test Product
    Table 71. MyHeritage Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) & (US$ Million)
    Table 72. MyHeritage Recent Developments
    Table 73. LabCorp Company Details
    Table 74. LabCorp Business Overview
    Table 75. LabCorp Direct-to-consumer Disease Risk and Health Test Product
    Table 76. LabCorp Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) & (US$ Million)
    Table 77. LabCorp Recent Developments
    Table 78. Myriad Genetics Company Details
    Table 79. Myriad Genetics Business Overview
    Table 80. Myriad Genetics Direct-to-consumer Disease Risk and Health Test Product
    Table 81. Myriad Genetics Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) & (US$ Million)
    Table 82. Myriad Genetics Recent Developments
    Table 83. Ancestry.com Company Details
    Table 84. Ancestry.com Business Overview
    Table 85. Ancestry.com Direct-to-consumer Disease Risk and Health Test Product
    Table 86. Ancestry.com Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) & (US$ Million)
    Table 87. Ancestry.com Recent Developments
    Table 88. Quest Diagnostics Company Details
    Table 89. Quest Diagnostics Business Overview
    Table 90. Quest Diagnostics Direct-to-consumer Disease Risk and Health Test Product
    Table 91. Quest Diagnostics Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) & (US$ Million)
    Table 92. Quest Diagnostics Recent Developments
    Table 93. Gene By Gene Company Details
    Table 94. Gene By Gene Business Overview
    Table 95. Gene By Gene Direct-to-consumer Disease Risk and Health Test Product
    Table 96. Gene By Gene Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) & (US$ Million)
    Table 97. Gene By Gene Recent Developments
    Table 98. DNA Diagnostics Center Company Details
    Table 99. DNA Diagnostics Center Business Overview
    Table 100. DNA Diagnostics Center Direct-to-consumer Disease Risk and Health Test Product
    Table 101. DNA Diagnostics Center Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) & (US$ Million)
    Table 102. DNA Diagnostics Center Recent Developments
    Table 103. Invitae Company Details
    Table 104. Invitae Business Overview
    Table 105. Invitae Direct-to-consumer Disease Risk and Health Test Product
    Table 106. Invitae Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) & (US$ Million)
    Table 107. Invitae Recent Developments
    Table 108. IntelliGenetics Company Details
    Table 109. IntelliGenetics Business Overview
    Table 110. IntelliGenetics Direct-to-consumer Disease Risk and Health Test Product
    Table 111. IntelliGenetics Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) & (US$ Million)
    Table 112. IntelliGenetics Recent Developments
    Table 113. Ambry Genetics Company Details
    Table 114. Ambry Genetics Business Overview
    Table 115. Ambry Genetics Direct-to-consumer Disease Risk and Health Test Product
    Table 116. Ambry Genetics Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) & (US$ Million)
    Table 117. Ambry Genetics Recent Developments
    Table 118. Living DNA Company Details
    Table 119. Living DNA Business Overview
    Table 120. Living DNA Direct-to-consumer Disease Risk and Health Test Product
    Table 121. Living DNA Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) & (US$ Million)
    Table 122. Living DNA Recent Developments
    Table 123. EasyDNA Company Details
    Table 124. EasyDNA Business Overview
    Table 125. EasyDNA Direct-to-consumer Disease Risk and Health Test Product
    Table 126. EasyDNA Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) & (US$ Million)
    Table 127. EasyDNA Recent Developments
    Table 128. Pathway Genomics Company Details
    Table 129. Pathway Genomics Business Overview
    Table 130. Pathway Genomics Direct-to-consumer Disease Risk and Health Test Product
    Table 131. Pathway Genomics Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) & (US$ Million)
    Table 132. Pathway Genomics Recent Developments
    Table 133. Centrillion Technology Company Details
    Table 134. Centrillion Technology Business Overview
    Table 135. Centrillion Technology Direct-to-consumer Disease Risk and Health Test Product
    Table 136. Centrillion Technology Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) & (US$ Million)
    Table 137. Centrillion Technology Recent Developments
    Table 138. Xcode Company Details
    Table 139. Xcode Business Overview
    Table 140. Xcode Direct-to-consumer Disease Risk and Health Test Product
    Table 141. Xcode Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) & (US$ Million)
    Table 142. Xcode Recent Developments
    Table 143. Color Genomics Company Details
    Table 144. Color Genomics Business Overview
    Table 145. Color Genomics Direct-to-consumer Disease Risk and Health Test Product
    Table 146. Color Genomics Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) & (US$ Million)
    Table 147. Color Genomics Recent Developments
    Table 148. Anglia DNA Services Company Details
    Table 149. Anglia DNA Services Business Overview
    Table 150. Anglia DNA Services Direct-to-consumer Disease Risk and Health Test Product
    Table 151. Anglia DNA Services Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) & (US$ Million)
    Table 152. Anglia DNA Services Recent Developments
    Table 153. African Ancestry Company Details
    Table 154. African Ancestry Business Overview
    Table 155. African Ancestry Direct-to-consumer Disease Risk and Health Test Product
    Table 156. African Ancestry Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) & (US$ Million)
    Table 157. African Ancestry Recent Developments
    Table 158. Canadian DNA Services Company Details
    Table 159. Canadian DNA Services Business Overview
    Table 160. Canadian DNA Services Direct-to-consumer Disease Risk and Health Test Product
    Table 161. Canadian DNA Services Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) & (US$ Million)
    Table 162. Canadian DNA Services Recent Developments
    Table 163. DNA Family Check Company Details
    Table 164. DNA Family Check Business Overview
    Table 165. DNA Family Check Direct-to-consumer Disease Risk and Health Test Product
    Table 166. DNA Family Check Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) & (US$ Million)
    Table 167. DNA Family Check Recent Developments
    Table 168. Alpha Biolaboratories Company Details
    Table 169. Alpha Biolaboratories Business Overview
    Table 170. Alpha Biolaboratories Direct-to-consumer Disease Risk and Health Test Product
    Table 171. Alpha Biolaboratories Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) & (US$ Million)
    Table 172. Alpha Biolaboratories Recent Developments
    Table 173. Test Me DNA Company Details
    Table 174. Test Me DNA Business Overview
    Table 175. Test Me DNA Direct-to-consumer Disease Risk and Health Test Product
    Table 176. Test Me DNA Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) & (US$ Million)
    Table 177. Test Me DNA Recent Developments
    Table 178. 23 Mofang Company Details
    Table 179. 23 Mofang Business Overview
    Table 180. 23 Mofang Direct-to-consumer Disease Risk and Health Test Product
    Table 181. 23 Mofang Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) & (US$ Million)
    Table 182. 23 Mofang Recent Developments
    Table 183. Genetic Health Company Details
    Table 184. Genetic Health Business Overview
    Table 185. Genetic Health Direct-to-consumer Disease Risk and Health Test Product
    Table 186. Genetic Health Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) & (US$ Million)
    Table 187. Genetic Health Recent Developments
    Table 188. DNA Services of America Company Details
    Table 189. DNA Services of America Business Overview
    Table 190. DNA Services of America Direct-to-consumer Disease Risk and Health Test Product
    Table 191. DNA Services of America Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) & (US$ Million)
    Table 192. DNA Services of America Recent Developments
    Table 193. Shuwen Health Sciences Company Details
    Table 194. Shuwen Health Sciences Business Overview
    Table 195. Shuwen Health Sciences Direct-to-consumer Disease Risk and Health Test Product
    Table 196. Shuwen Health Sciences Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) & (US$ Million)
    Table 197. Shuwen Health Sciences Recent Developments
    Table 198. Mapmygenome Company Details
    Table 199. Mapmygenome Business Overview
    Table 200. Mapmygenome Direct-to-consumer Disease Risk and Health Test Product
    Table 201. Mapmygenome Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) & (US$ Million)
    Table 202. Mapmygenome Recent Developments
    Table 203. Full Genomes Company Details
    Table 204. Full Genomes Business Overview
    Table 205. Full Genomes Direct-to-consumer Disease Risk and Health Test Product
    Table 206. Full Genomes Revenue in Direct-to-consumer Disease Risk and Health Test Business (2017-2022) & (US$ Million)
    Table 207. Full Genomes Recent Developments
    Table 208. Research Programs/Design for This Report
    Table 209. Key Data Information from Secondary Sources
    Table 210. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Direct-to-consumer Disease Risk and Health Test Market Share by Type: 2021 VS 2028
    Figure 2. Celiac Disease Features
    Figure 3. Parkinson Disease Features
    Figure 4. Alzheimer Disease Features
    Figure 5. Other Features
    Figure 6. Global Direct-to-consumer Disease Risk and Health Test Market Share by Application: 2021 VS 2028
    Figure 7. Online Case Studies
    Figure 8. Offline Case Studies
    Figure 9. Direct-to-consumer Disease Risk and Health Test Report Years Considered
    Figure 10. Global Direct-to-consumer Disease Risk and Health Test Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 11. Global Direct-to-consumer Disease Risk and Health Test Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Direct-to-consumer Disease Risk and Health Test Market Share by Region: 2021 VS 2028
    Figure 13. Global Direct-to-consumer Disease Risk and Health Test Market Share by Players in 2021
    Figure 14. Global Top Direct-to-consumer Disease Risk and Health Test Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Direct-to-consumer Disease Risk and Health Test as of 2021)
    Figure 15. The Top 10 and 5 Players Market Share by Direct-to-consumer Disease Risk and Health Test Revenue in 2021
    Figure 16. North America Direct-to-consumer Disease Risk and Health Test Market Size YoY (2017-2028) & (US$ Million)
    Figure 17. North America Direct-to-consumer Disease Risk and Health Test Market Size Market Share by Type (2017-2028)
    Figure 18. North America Direct-to-consumer Disease Risk and Health Test Market Size Market Share by Application (2017-2028)
    Figure 19. North America Direct-to-consumer Disease Risk and Health Test Market Size Share by Country (2017-2028)
    Figure 20. United States Direct-to-consumer Disease Risk and Health Test Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Canada Direct-to-consumer Disease Risk and Health Test Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Direct-to-consumer Disease Risk and Health Test Market Size YoY (2017-2028) & (US$ Million)
    Figure 23. Europe Direct-to-consumer Disease Risk and Health Test Market Size Market Share by Type (2017-2028)
    Figure 24. Europe Direct-to-consumer Disease Risk and Health Test Market Size Market Share by Application (2017-2028)
    Figure 25. Europe Direct-to-consumer Disease Risk and Health Test Market Size Share by Country (2017-2028)
    Figure 26. Germany Direct-to-consumer Disease Risk and Health Test Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. France Direct-to-consumer Disease Risk and Health Test Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. U.K. Direct-to-consumer Disease Risk and Health Test Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Italy Direct-to-consumer Disease Risk and Health Test Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Russia Direct-to-consumer Disease Risk and Health Test Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Nordic Countries Direct-to-consumer Disease Risk and Health Test Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Asia-Pacific Direct-to-consumer Disease Risk and Health Test Market Size YoY (2017-2028) & (US$ Million)
    Figure 33. Asia Pacific Direct-to-consumer Disease Risk and Health Test Market Size Market Share by Type (2017-2028)
    Figure 34. Asia Pacific Direct-to-consumer Disease Risk and Health Test Market Size Market Share by Application (2017-2028)
    Figure 35. Asia Pacific Direct-to-consumer Disease Risk and Health Test Market Size Share by Region (2017-2028)
    Figure 36. China Direct-to-consumer Disease Risk and Health Test Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Japan Direct-to-consumer Disease Risk and Health Test Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. South Korea Direct-to-consumer Disease Risk and Health Test Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Southeast Asia Direct-to-consumer Disease Risk and Health Test Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. India Direct-to-consumer Disease Risk and Health Test Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Australia Direct-to-consumer Disease Risk and Health Test Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 42. Latin America Direct-to-consumer Disease Risk and Health Test Market Size YoY (2017-2028) & (US$ Million)
    Figure 43. Latin America Direct-to-consumer Disease Risk and Health Test Market Size Market Share by Type (2017-2028)
    Figure 44. Latin America Direct-to-consumer Disease Risk and Health Test Market Size Market Share by Application (2017-2028)
    Figure 45. Latin America Direct-to-consumer Disease Risk and Health Test Market Size Share by Country (2017-2028)
    Figure 46. Mexico Direct-to-consumer Disease Risk and Health Test Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Brazil Direct-to-consumer Disease Risk and Health Test Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 48. Middle East & Africa Direct-to-consumer Disease Risk and Health Test Market Size YoY (2017-2028) & (US$ Million)
    Figure 49. Middle East and Africa Direct-to-consumer Disease Risk and Health Test Market Size Market Share by Type (2017-2028)
    Figure 50. Middle East and Africa Direct-to-consumer Disease Risk and Health Test Market Size Market Share by Application (2017-2028)
    Figure 51. Middle East and Africa Direct-to-consumer Disease Risk and Health Test Market Size Share by Country (2017-2028)
    Figure 52. Turkey Direct-to-consumer Disease Risk and Health Test Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 53. Saudi Arabia Direct-to-consumer Disease Risk and Health Test Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. UAE Direct-to-consumer Disease Risk and Health Test Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 55. 23andMe Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
    Figure 56. MyHeritage Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
    Figure 57. LabCorp Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
    Figure 58. Myriad Genetics Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
    Figure 59. Ancestry.com Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
    Figure 60. Quest Diagnostics Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
    Figure 61. Gene By Gene Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
    Figure 62. DNA Diagnostics Center Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
    Figure 63. Invitae Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
    Figure 64. IntelliGenetics Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
    Figure 65. Ambry Genetics Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
    Figure 66. Living DNA Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
    Figure 67. EasyDNA Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
    Figure 68. Pathway Genomics Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
    Figure 69. Centrillion Technology Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
    Figure 70. Xcode Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
    Figure 71. Color Genomics Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
    Figure 72. Anglia DNA Services Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
    Figure 73. African Ancestry Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
    Figure 74. Canadian DNA Services Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
    Figure 75. DNA Family Check Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
    Figure 76. Alpha Biolaboratories Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
    Figure 77. Test Me DNA Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
    Figure 78. 23 Mofang Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
    Figure 79. Genetic Health Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
    Figure 80. DNA Services of America Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
    Figure 81. Shuwen Health Sciences Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
    Figure 82. Mapmygenome Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
    Figure 83. Full Genomes Revenue Growth Rate in Direct-to-consumer Disease Risk and Health Test Business (2017-2022)
    Figure 84. Bottom-up and Top-down Approaches for This Report
    Figure 85. Data Triangulation
    Figure 86. Key Executives Interviewed